Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia

H. W. Moon, S. Shin, H. Y. Kim, Y. R. Kim, H. I. Cho, S. S. Yoon, S. Park, B. K. Kim, H. Chun, H. C. Kim, C. J. Park, Y. H. Min, D. Soon Lee

Research output: Contribution to journalArticlepeer-review

5 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO<sup>+</sup> acute myelogenous leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences